Arena Study Falls Short in Treatment for Insomnia
Preliminary data from Arena Pharmaceuticals’ Phase IIb clinical trial of APD125 as a treatment for insomnia did not meet the trial’s primary or secondary endpoints.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.